CMS certification 320002
CHRISTUS St Vincent Regional Medical Center
455 St Michael's Drive, Santa Fe, NM 87505
CHRISTUS St Vincent Regional Medical Center has a CMS overall rating of 4 out of 5 stars. 71% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 22 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 6 and worse on 1. Emergency patients spend a median of 2 h 53 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 466 completed surveys, 23% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | NM | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 379 visits sampled · US median for EDs of the same volume: 3 h 22 min | 2 h 53 min | 2 h 43 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 23 visits sampled | 4 h 45 min | 4 h 34 min | 4 h 17 min |
| Left before being seen Lower is better · 47,570 patients | 1% | 3% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 42 patients | 36% | 50% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 122 patients | 75% | 54% | 65% |
How CHRISTUS St Vincent Regional Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| CHRISTUS St Vincent Regional Medical CenterThis hospital | 4/5 | 71% | 2 h 53 min | 6 better 1 worse |
| Presbyterian Santa Fe Medical CenterSame city | 5/5 | 75% | 3 h 45 min | 1 better |
| Presbyterian Espanola HospitalSame ZIP area · Espanola | Not rated | 80% | 2 h 48 min | 1 better |
| Los Alamos Medical CenterSame ZIP area · Los Alamos | Not rated | 69% | 2 h 48 min | No different |
| Holy Cross Hospital a Div of Taos Health SystemsSame ZIP area · Taos | 1/5 | 62% | 1 h 32 min | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Santa Fe.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 2,898 cases | Too few cases | 3.9% | 3.9% |
| Heart attack 300 cases | Too few cases | 11% | 11.9% |
| Heart failure 321 cases | Too few cases | 8.2% | 11.1% |
| Pneumonia 537 cases | Too few cases | 14.3% | 15.2% |
| Stroke 216 cases | Too few cases | 9.9% | 11.9% |
| COPD 73 cases | Too few cases | 7.8% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | Worse | 1.37 likely 1.01 – 1.74 | 1 |
| Deaths after a serious but treatable surgical complication 73 cases | No different | 160.46 per 1,000 likely 105.2 per 1,000 – 215.71 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 4,331 cases | Worse | 2.17 per 1,000 likely 1.44 per 1,000 – 2.9 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 5,581 cases | No different | 0.16 per 1,000 likely 0 per 1,000 – 0.37 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 5,406 cases | No different | 0.26 per 1,000 likely 0.06 per 1,000 – 0.46 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,203 cases | No different | 2.41 per 1,000 likely 0.86 per 1,000 – 3.96 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 242 cases | No different | 1.48 per 1,000 likely 0 per 1,000 – 3.11 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 219 cases | No different | 8.72 per 1,000 likely 0.17 per 1,000 – 17.26 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,283 cases | No different | 3.33 per 1,000 likely 1.29 per 1,000 – 5.37 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 222 cases | No different | 4.46 per 1,000 likely 0.45 per 1,000 – 8.47 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 299 cases | No different | 1.65 per 1,000 likely 0.17 per 1,000 – 3.13 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,120 cases | No different | 1.06 per 1,000 likely 0.09 per 1,000 – 2.03 per 1,000 | 1.06 per 1,000 |
1 more measure had too few cases here to report.
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 1.5 likely 0.48 – 3.61 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 1.03 likely 0.33 – 2.49 | 1 |
| Surgical site infections after colon surgery | No different | 0.61 likely 0.1 – 2.01 | 1 |
| MRSA bloodstream infections | No different | 1.09 likely 0.28 – 2.97 | 1 |
| C. diff intestinal infections | Better | 0.31 likely 0.15 – 0.59 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 327 cases | Too few cases | 12.7% | 14.4% |
| Readmitted after heart failure 414 cases | Too few cases | 19.6% | 21.3% |
| Readmitted after pneumonia 741 cases | Too few cases | 15.9% | 17.3% |
| Readmitted after COPD 112 cases | Too few cases | 19.1% | 20% |
| Days back in hospital after a heart attack 283 cases | Too few cases | -9 days per 100 | — |
| Days back in hospital after heart failure 349 cases | Too few cases | -34.8 days per 100 | — |
| Days back in hospital after pneumonia 573 cases | Too few cases | -29.9 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 415 cases | No different | 14.7 per 1,000 likely 11.1 per 1,000 – 19.4 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 269 cases | No different | 9.2 per 100 likely 6.7 per 100 – 12.4 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 269 cases | No different | 5.7 per 100 likely 3.9 per 100 – 8 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,486 cases | Better | 0.8 likely 0.6 – 1 | — |
3 more measures had too few cases here to report.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $113
- 2020 $12,930
- 2021 $680
- 2022 $15,130
- 2023 $252,654
- 2024 $157,538
- 2025 $275,254
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Speaking, teaching and other services | $22,250 | 9 |
| Space rental and facility fees | $20,175 | 4 |
| Medical devices and supplies on long-term loan | $4,639 | 3 |
| Debt forgiveness | $30 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Coherus Oncology, Inc. | $72,525 | 4 |
| AstraZeneca UK Limited | $71,751 | 1 |
| Janssen Research & Development, LLC | $58,289 | 8 |
| Pfizer INC. | $27,866 | 8 |
| AstraZeneca Pharmaceuticals LP | $22,728 | 3 |
| Progenics Pharmaceuticals, INC. | $5,175 | 1 |
| Bayer Healthcare Pharmaceuticals Inc. | $5,000 | 1 |
| Array Biopharma INC | $5,000 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| CAMBRIA-1 A Phase III, Open-Label,Randomised Study to Assess the Efficacy and Safety of Extended Therapy with Camizestrant (AZD9833, a Next Generatio… AstraZeneca UK Limited | $71,751 |
| CHS38802 Coherus Oncology, Inc. | $51,465 |
| A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) versus Daratumumab SC, Lenalidomide, an… Janssen Research & Development, LLC | $31,675 |
| A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) versus Daratumumab SC, Lenalidomide, an… Janssen Research & Development, LLC | $23,750 |
| CHS11402 Coherus Oncology, Inc. | $21,060 |
| A Phase III Randomized Open-Label Sponsor-Blinded Multicenter Study of Durvalumab in Combination with Tremelimumab Lenvatinib Given Concurrently wit… AstraZeneca Pharmaceuticals LP | $12,728 |
| A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY OF PF06821497 MEVROMETOSTAT WITH ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT PROSTATE … PFIZER INC. | $11,506 |
| A Post-authorization Safety Study to Evaluate the Incidence of and Risk Factors for Severe and Fatal Infusionrelated Reactions in Participants Treate… Janssen Research & Development, LLC | $2,864 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about CHRISTUS St Vincent Regional Medical Center
Is CHRISTUS St Vincent Regional Medical Center a good hospital?
CHRISTUS St Vincent Regional Medical Center has a CMS overall rating of 4 out of 5 stars. Of the 22 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 6 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend CHRISTUS St Vincent Regional Medical Center?
71% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 466 completed HCAHPS surveys.
How long is the wait in the CHRISTUS St Vincent Regional Medical Center emergency room?
Emergency patients spend a median of 2 h 53 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does CHRISTUS St Vincent Regional Medical Center receive money from drug and device companies?
Drug and device makers reported $275,254 in payments to CHRISTUS St Vincent Regional Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.